Transcriptional responses of the nerve agent-sensitive brain regions amygdala, hippocampus, piriform cortex, septum, and thalamus following exposure to the organophosphonate anticholinesterase sarin

Journal of Neuroinflammation

James F Dillman²  James L Meyerhoff³  Christopher L Robison¹  Lucille A Lumley¹  Kimberly D Spradling² 

[1] Neurobehavioral Toxicology Branch, US Army Medical Research Institute of Chemical Defense (USAMRICD), 3100 Ricketts Point Road, Aberdeen Proving Ground, MD 21010-5400, USA;Cell and Molecular Biology Branch, US Army Medical Research Institute of Chemical Defense (USAMRICD), 3100 Ricketts Point Road, Aberdeen Proving Ground, MD 21010-5400, USA;US Army Center for Environmental Health Research, 568 Doughten Drive, Fort Detrick, MD 21702-5010, USA

关键词: Transcriptomics;    Microarray;    Chemokine;    Cytokine;    Neuroinflammation;    Seizure;    Sarin;    Organophosphate;    Chemical Warfare;    Nerve Agent;   

Others  :  1213235
DOI  :  10.1186/1742-2094-8-84

 received in 2011-04-27, accepted in 2011-07-21,  发布年份 2011

【 摘 要 】

Background

Although the acute toxicity of organophosphorus nerve agents is known to result from acetylcholinesterase inhibition, the molecular mechanisms involved in the development of neuropathology following nerve agent-induced seizure are not well understood. To help determine these pathways, we previously used microarray analysis to identify gene expression changes in the rat piriform cortex, a region of the rat brain sensitive to nerve agent exposure, over a 24-h time period following sarin-induced seizure. We found significant differences in gene expression profiles and identified secondary responses that potentially lead to brain injury and cell death. To advance our understanding of the molecular mechanisms involved in sarin-induced toxicity, we analyzed gene expression changes in four other areas of the rat brain known to be affected by nerve agent-induced seizure (amygdala, hippocampus, septum, and thalamus).

Methods

We compared the transcriptional response of these four brain regions to sarin-induced seizure with the response previously characterized in the piriform cortex. In this study, rats were challenged with 1.0 × LD₅₀ sarin and subsequently treated with atropine sulfate, 2-pyridine aldoxime methylchloride, and diazepam. The four brain regions were collected at 0.25, 1, 3, 6, and 24 h after seizure onset, and total RNA was processed for microarray analysis.

Results

Principal component analysis identified brain region and time following seizure onset as major sources of variability within the dataset. Analysis of variance identified genes significantly changed following sarin-induced seizure, and gene ontology analysis identified biological pathways, functions, and networks of genes significantly affected by sarin-induced seizure over the 24-h time course. Many of the molecular functions and pathways identified as being most significant across all of the brain regions were indicative of an inflammatory response. There were also a number of molecular responses that were unique for each brain region, with the thalamus having the most distinct response to nerve agent-induced seizure.

Conclusions

Identifying the molecular mechanisms involved in sarin-induced neurotoxicity in these sensitive brain regions will facilitate the development of novel therapeutics that can potentially provide broad-spectrum protection in five areas of the central nervous system known to be damaged by nerve agent-induced seizure.

【 授权许可】

   
2011 Spradling et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

Figure 10.

Figure 11.

Figure 12.

Figure 5.

【 参考文献 】

• [1]McDonough JH Jr, Shih TM: Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 1997, 21:559-579.
• [2]Bajgar J: Complex view on poisoning with nerve agents and organophosphates. Acta Medica (Hradec Králové) 2005, 48(1):3-21.
• [3]Aroniadou-Anderjaska V, Figueiredo TH, Apland JP, Qashu F, Braga MFM: Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus. Neurotoxicology 2009, 30:772-776.
• [4]Shih TM, Duniho SM, McDonough JH Jr: Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol 2003, 188:69-80.
• [5]Myhrer T, Enger S, Aas P: Efficacy of immediate and subsequent therapies against soman-induced seizures and lethality in rats. Basic Clin Pharmacol Toxicol 2006, 98:184-191.
• [6]Myhrer T: Neuronal structures involved in the induction and propagation of seizures caused by nerve agents: implications for medical treatment. Toxicology 2007, 239(1-2):1-14.
• [7]Brown MA, Brix KA: Review of health consequences from high-, intermediate and low-level exposure to organophosphorus nerve agents. J Appl Toxicol 1998, 18:393-408.
• [8]Bajgar J, Ševelová L, Krejčová G, Fusek J, Vachek J, Kassa J, Herink J: Biochemical and behavioral effects of soman vapors in low concentrations. Inhal Toxicol 2004, 16:497-507.
• [9]Myhrer T, Enger S, Aas P: Anticonvulsant effects of damage to structures involved in seizure induction in rats exposed to soman. Neurotoxicology 2007, 28:819-828.
• [10]McDonough JH Jr, Dochterman LW, Smith CD, Shih TM: Protection against nerve agent induced neuropathology, but not cardiac pathology, is associated with the anti-convulsant action of drug treatment. Neurotoxicology 1995, 15:123-132.
• [11]Baille V, Clarke PGH, Brochier G, Dorandeu F, Verna JM, Four E, Lallement G, Carpentier P: Soman-induced convulsions: the neuropathology revisited. Toxicology 2005, 215:1-24.
• [12]Angoa-Pérez M, Kreipke CW, Thomas DM, Van Shura KE, Lyman M, McDonough JH, Kuhn DM: Soman increases neuronal COX-2 levels: possible link between seizures and protracted neuronal damage. Neurotoxicology 2010, 31:738-746.
• [13]Zimmer LA, Ennis M, Shipley MT: Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain regions. J Comp Neurol 1997, 378:482-492.
• [14]Racine RJ: Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972, 32(3):281-294.
• [15]Dillman JF III, Phillips CS, Dorsch LM, Croxton MD, Hege AI, Sylvester AJ, Moran TS, Sciuto AM: Genomic analysis of rodent pulmonary tissue following bis-(2-chloroethyl) sulfide exposure. Chem Res Toxicol 2005, 18:28-34.
• [16]Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31(4):1-8.
• [17]Pearson K: On lines and planes of closest fit to systems of points in space. Philos Mag 1901, 2:559-572.
• [18]Svensson I, Waara L, Johansson L, Bucht A, Cassel G: Soman-induced interleukin-1β mRNA and protein in rat brain. Neurotoxicology 2001, 22:355-362.
• [19]Williams AJ, Berti R, Yao C, Price RA, Velarde LC, Koplovitz I, Schultz SM, Tortella FC, Dave JR: Central neuro-inflammatory gene response following soman exposure in the rat. Neurosci Lett 2003, 349:147-150.
• [20]Svensson I, Waara L, Cassel G: Effects of HI 6, diazepam and atropine on soman-induced IL-1β protein in rat brain. Neurotoxicology 2005, 26:173-181.
• [21]Chapman S, Kadar T, Gilat E: Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain. Neurotoxicology 2006, 27:277-283.
• [22]Damodaran TV, Greenfield ST, Patel AG, Dressman HK, Lin SK, Abou-Donia MB: Toxicogenomic studies of the rat brain at an early time point following acute sarin exposure. Neurochem Res 2006, 31:367-381.
• [23]Damodaran TV, Patel AG, Greenfield ST, Dressman HK, Lin SM, Abou-Donia MB: Gene expression profiles of the rat brain both immediately and 3 months following acute sarin exposure. Biochem Pharmacol 2006, 71:497-520.
• [24]Dhote F, Peinnequin A, Carpentier P, Baille V, Delacour C, Foquin A, Lallement G, Dorandeu F: Prolonged inflammatory gene response following soman-induced seizures in mice. Toxicology 2007, 238:166-176.
• [25]Dillman JF III, Phillips CS, Kniffin DM, Tompkins CP, Hamilton TA, Kan RK: Gene expression profiling of rat hippocampus following exposure to the acetylcholinesterase inhibitor soman. Chem Res Toxicol 2009, 22(4):633-638.
• [26]Johnson EA, Kan RK: The acute phase response and soman-induced status epilepticus: temporal and regional changes in rat brain cytokine concentrations. J Neuroinflammation 2010, 7(40):1-9.
• [27]Carpentier P, Foquin A, Rondouin G, LernerNatoli M, deGroot DMG, Lallement G: Effects of atropine sulphate on seizure activity and brain damage produced by soman in guinea pigs: ECoG correlates of neuropathology. Neurotoxicology 2000, 4:521-540.
• [28]Lemercier G, Carpentier P, Sentenac-Roumanou H, Moralis P: Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol (Berlin) 1983, 61:123-129.
• [29]Lallement G, Mestries JC, Privat A, Brochier G, Baubichon D, Carpentier P, Kamenka JM, Sentenac-Roumanou H, Burckhart MF, Peoc'h M: GK 11: promising additional neuroprotective therapy for organophosphate poisoning. Neurotoxicology 1997, 18(3):851-856.
• [30]Lallement G, Clarencon D, Masqueliez C, Baubichon D, Galonnier M, Burckhart MF, Peoc'h M, Mestries JC: Nerve agent poisoning in primates: antilethal, anti-epileptic and neuroprotective effects of GK-11. Arch Toxicol 1998, 72(2):84-92.
• [31]De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F, De Luigi A, Garattini S, Vezzani A: Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000, 12:2623-2633.
• [32]Viviani B, Bartesaghi S, Corsini E, Galli CL, Marinovich M: Cytokines role in neurodegenerative events. Toxicol Lett 2004, 149:85-89.
• [33]Voutsinos-Porche B, Koning E, Kaplan H, Ferrandon A, Guenounou M, Nehlig A, Motte J: Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol Dis 2004, 17:385-402.
• [34]Vezzani A: Inflammation and epilepsy. Curr Rev Basic Sci 2005, 5(1):1-6.
• [35]Choi J, Koh S: Yonsei Med J. 2008, 49(1):1-18.
• [36]Morganti-Kossmann MC, Kossmann T, Wahl SM: Cytokines and neuropathology. Trends Pharmacol Sci 1992, 13:286-291.
• [37]Lehtimaki KA, Peltola J, Koskikallio E, Keranen T, Honkaniemi J: Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Mol Brain Res 2003, 110:253-260.
• [38]Dinarello CA, Ikejima T, Warner SJ, Orencole SF, Lonnemann G, Cannon JG, Libby P: Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol 1987, 139:1902-1910.
• [39]Moynagh PN, Williams DC, O'Neill LA: Interleukin-1 activates transcription factor NFκB in glial cells. Biochem J 1993, 294:343-347.
• [40]Berridge MJ: Unlocking the secrets of cell signaling. Annu Rev Physiol 2005, 67:1-21.
• [41]Filbert M, Levine E, Ballough G: Neuroprotection for nerve agent-induced brain damage by blocking delayed calcium overload: a review. J Med Chem Biol Radiol Def 2005, 3:1-21.
• [42]Ye ZC, Sontheimer H: Cytokine modulation of glial glutamate uptake: A possible involvement of nitric oxide. Neuroreport 1996, 7(13):2181-2185.
• [43]Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M: Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003, 23:8692-8700.
• [44]Ravizza T, Lucas SM, Balosso S, Bernardino L, Ku G, Noé F, Malva J, Randle JCR, Allan S, Vezzani A: Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia 2006, 47(7):1160-1168.
• [45]Ravizza T, Gagliardi B, Noé F, Boer K, Aronica E, Vezzani A: Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008, 29:142-160.
• [46]Carvey PM, Hendey B, Monahan AJ: The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. J Neurochem 2009, 111(2):291-314.
• [47]Bolton SJ, Anthony DC, Perry VH: Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neurosci 1998, 86(4):1245-1257.
• [48]Mayhan WG: Cellular mechanisms by which tumor necrosis factor-α produces disruption of the blood-brain barrier. Brain Res 2002, 927:144-152.
• [49]Allan SM, Tyrrell PJ, Rothwell NJ: Interleukin-1 and neuronal injury. Nat Rev Immunol 2005, 5(8):629-640.
• [50]Abdel-Rahman A, Shetty AK, Abou-Donia MB: Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: dose-response relationships. Neurosci 2002, 113(3):721-741.
• [51]Spradling , et al., in press.